Shen, Chen-Tian <br/><br/>
Metformin reduces glycometabolism of papillary thyroid carcinoma in vitro and in vivo.  [electronic resource] 

 -  Journal of molecular endocrinology  01 2017 
 - 15-23 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1479-6813 
<br/><br/><label>Standard No.: </label>10.1530/JME-16-0134  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AMP-Activated Protein Kinases--metabolism<br/>Animals<br/>Carcinoma, Papillary--diagnostic imaging<br/>Cell Line, Tumor<br/>Cell Survival<br/>Disease Models, Animal<br/>Female<br/>Fluorodeoxyglucose F18<br/>Gene Expression<br/>Glucose--metabolism<br/>Glucose Transporter Type 1--genetics<br/>Heterografts<br/>Hexokinase--genetics<br/>Humans<br/>Immunohistochemistry<br/>Metabolic Networks and Pathways--drug effects<br/>Metformin--pharmacology<br/>Positron Emission Tomography Computed Tomography--methods<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Signal Transduction<br/>TOR Serine-Threonine Kinases--metabolism<br/>Thyroid Cancer, Papillary<br/>Thyroid Neoplasms--diagnostic imaging